In 2011, the then 51-year-old was diagnosed with stage four oropharyngeal cancer. “I’d never been a smoker or a drinker, let ...
Knowledge of the association between human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma (OPSCC) is poor and ...
MCLA-145 is under clinical development by Merus and currently in Phase I for Oropharyngeal Cancer. According to GlobalData, Phase I drugs for Oropharyngeal Cancer have an 81% phase transition success ...
Exlinkibart is under clinical development by Lyvgen Biopharma and currently in Phase II for Oropharyngeal Cancer.
EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024 Paris, France, 9 December 2024 – EnnoDC, a clinical-stage biotech company ...
Oropharyngeal cancer (OPC) rates are rising among people living with HIV, and Bansal is determined to find out why by exploring how chronic HIV infection influences appears to drive development of ...
The Company currently has three active clinical trials in various stages of clinical development, addressing oncology and infectious disease indications. Its lead asset, CD40HVac is currently in a ...